This inventor holds 7 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Duality Biologics (Suzhou) Co., Ltd., Shanghai University. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Innovations of Hongxia Shen in Anti-Tumor Compounds
Introduction
Hongxia Shen is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of anti-tumor research, holding a total of seven patents. Her work focuses on the development of compounds that can potentially aid in cancer treatment.
Latest Patents
Among her latest patents is an innovative anti-tumor compound and its preparation method. This application details a compound or its various forms, including tautomers, mesomers, racemates, enantiomers, diastereoisomers, or mixtures thereof, as well as pharmaceutically acceptable salts. The preparation method and use of this compound are also elaborated upon, showcasing its potential in therapeutic applications.
Career Highlights
Hongxia Shen has worked with notable organizations, including Duality Biologics (Suzhou) Co., Ltd. and Shanghai University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues such as Yu Zhang and Zhongyuan Zhu. These partnerships have further enriched her research endeavors and innovations.
Conclusion
Hongxia Shen's work in developing anti-tumor compounds highlights her dedication to advancing cancer treatment. Her patents and collaborations reflect her significant impact in the field of medical research.